Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report)’s stock price shot up 25.6% during mid-day trading on Monday . The company traded as high as $0.25 and last traded at $0.2010. 3,114 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 13,128 shares. The stock had previously closed at $0.16.
Guided Therapeutics Price Performance
The stock has a market capitalization of $20.90 million, a price-to-earnings ratio of -5.00 and a beta of 0.38. The firm’s fifty day moving average is $0.25 and its 200-day moving average is $0.23.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last released its earnings results on Thursday, November 13th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.06 million during the quarter.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Further Reading
- Five stocks we like better than Guided Therapeutics
- What is a SEC Filing?
- onsemi Places a $6 Billion Bet on Its Own Stock
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- What is Insider Trading? What You Can Learn from Insider Trading
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
